Abstract

AbstractThree new 1,2,4,5‐tetraphenylimidazole derivatives, 9,9‐dimethyl‐10‐(4‐(2,4,5‐triphenyl‐1H‐imidazol‐1‐yl)phenyl)‐9,10‐dihydroacridine (DMAC‐TPI), 10‐(4‐(2,4,5‐triphenyl‐1H‐imidazol‐1‐yl)phenyl)‐10H‐phenoxazine (PXZ‐TPI), and 10‐(4‐(2,4,5‐triphenyl‐1H‐imidazol‐1‐yl)phenyl)‐10H‐phenothiazine (PTZ‐TPI), bearing different electron donors at the N1 position of the imidazole were synthesised and characterised. DMAC‐TPI and PXZ‐TPI showed narrow emission at λPL of 388 and 418 nm in toluene, and in doped films in Zeonex polymer (1 wt.%) at λPL 381 and 407 nm, respectively, with a full width at half maximum (FWHM) ranging 0.42‐0.44 eV. DMAC‐TPI and PXZ‐TPI are predicted to show very low oscillator strength for the low‐energy transitions, which aligns to the observed low photoluminescence quantum yields. Both molecules showed a singlet‐triplet energy gap (ΔEST of around 1.2 eV) that is much too large to enable reverse intersystem crossing and thermally activated delayed fluorescence. Connecting a donor group to TPI at the N1 position can lead to room temperature phosphorescence (RTP), as the example of PTZ‐TPI showed.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.